Health secretary backs Herceptin use
November 10, 2005North Stoke PCT will provide a mother of four with breast cancer drug Herceptin following mounting political and media pressure.Elaine …
Foundation Trust requirements relaxed
November 10, 2005The government is opening up Foundation Trust status to more hospitals as it looks to accelerate health service reform.NHS Trusts …
NICE unveils fast track plans
November 10, 2005NICE has unveiled plans to fast-track key new cancer drugs and other medicines through a new simplified appraisal process.The Institute …
Herbal medicines must prove safety
November 10, 2005Sales and Marketing
The marketing of herbal medicines will now face stricter regulation across the European Union following the introduction of new legislation. …
GSK loses out on UK Seroxat patent
November 10, 2005Sales and Marketing
GlaxoSmithKline has been defeated in a long-running battle over the UK patent on its antidepressant Seroxat.After four years of legal …
Agency to raise iron overload awareness for Novartis brand
November 10, 2005Medical Communications
Ruder Finn has been awarded the UK contract to promote Novartis' new chronic iron overload product Exjade in a campaign …
MSD patient safety campaign tackles counterfeits
November 10, 2005Sales and Marketing
Merck Sharp & Dohme has launched a public information campaign warning of the the dangers of buying 'lifestyle' drugs over …
New advertising checks could delay UK launches
November 10, 2005Sales and Marketing
The MHRA has conceded that checks on advertising and promotional materials for new prescription medicines could delay their UK launch …
Enhancing the drug development process
November 9, 2005Research and Development
MEDICAL SOLUTIONS SPONSORED FEATURERecently, we have seen a massive increase in our knowledge and understanding of the biochemical mechanisms that, …
Bextra suspension confirmed in EU
November 9, 2005Sales and Marketing
The European Commission has confirmed that Pfizer's Cox-II product Bextra will remain suspended from the market because of safety concerns.The …
Ebixa takes on Alzheimer’s market leaders
November 9, 2005Sales and Marketing
Lundbeck's Alzheimer's treatment Ebixa will compete directly with the leading treatments for the moderate form of the disease following an …
New Aptivus launched in Europe for resistant HIV
November 9, 2005Sales and Marketing
Boehringer Ingelheim's new treatment for patients with drug-resistant HIV has been approved by the EMEA.The prevalence of drug-resistant HIV is …
UK approval for severe asthma treatment Xolair
November 9, 2005Sales and Marketing
Novartis has received UK approval for Xolair, its novel monoclonal antibody treatment for severe persistent allergic asthma.The first drug in …
Tarceva receives approval for pancreatic cancer in the US
November 8, 2005Sales and Marketing
Roche and Genentech's Tarceva has been approved in the US for the treatment of pancreatic cancer – one of the …
Pharma’s changing salesforces
November 8, 2005Sales and Marketing
The traditional salesforce model has served the industry well for 30-40 years and has been one of the biggest drivers …
US acquisitions a coup for Cambridge Antibody
November 8, 2005Research and Development
Cambridge Antibody Technology has bought two promising oncology candidates from US biotech company Genencor, and has established its first research …
Industry’s European price ‘free riding’ claim refuted
November 8, 2005Sales and Marketing
Long-standing claims that the US has been burdened with high medicines prices because of 'free riding' by European countries have …
NHS clinical leaders oppose mergers
November 8, 2005More than three quarters of lead clinicians believe proposed mergers of Primary Care Trusts will harm patient care, according to …
R&D Scoreboard poor gauge of pharma investment in the UK
November 8, 2005Research and Development AstraZeneca, GSK, Pfizer, R&D, R&D scoreboard
The R&D Scoreboard is fundamentally flawed as a measure of R&D investment in the UK and pharmaceutical companies are continuing …
Marketers and levels of leadership
November 7, 2005Sales and Marketing
Trends come and go in the pharma industry – just like in any other – but one which has stuck …
Latest content
